China News Service, Brussels, November 25 (Reporter De Yongjian) After reaching a new crown vaccine order agreement with six pharmaceutical companies, European Commission President Von der Lein revealed on the 25th that the EU's new crown vaccination is expected to start before the end of December this year.

  Von der Lein stated at the plenary session of the European Parliament that the new crown pneumonia epidemic in EU member states is still severe. There were an average of 3,000 deaths a day last week, which has become the leading cause of death for citizens of EU member states. If you repeat the mistakes made this summer , Too quickly or too much to lift the ban, the third wave of epidemics may usher in after Christmas this year.

  Later, she said that "there is good news now." The EU has reached an agreement with six pharmaceutical companies to order the new crown vaccine. "The first batch of vaccinators in the EU may be vaccinated before the end of December this year", as if "seeing the end of the tunnel" Dawn".

  Von Delane also called for vaccination to be as important as vaccines. Now EU member states must be prepared to ensure the supply of syringes and cold chains, prepare vaccination centers, and train relevant medical personnel to smoothly distribute and vaccinate hundreds of millions of new crowns. vaccine.

  Since August of this year, the European Union has successively cooperated with AstraZeneca, Sanofi and GlaxoSmithKline in the United Kingdom, New Biotechnology Corporation in Germany and Pfizer Pharmaceutical Co., Ltd. in the United States, Janssen Pharmaceuticals under Johnson & Johnson in the United States, and the German "cure" vaccine company (CureVac) reached a new crown vaccine order agreement. On the 24th, Von der Lein announced that the European Union had reached an agreement with Modena of the United States and decided to order 160 million doses of Modena's new crown vaccine. So far, the total number of new crown vaccines ordered by the EU is close to 2 billion doses. On average, each citizen of an EU member state can receive about 4 doses of vaccine.

  At present, the European Union has determined that all new crown vaccines must be approved by the European Medicines Agency before they can be put on the market. Thereafter, the European Union will distribute vaccines to member states at the same time, under the same conditions, and in proportion to the population; previously, the German Biotech Company and Pfizer Pharmaceutical Co., Ltd. once said that if all goes well, the new crown vaccine jointly developed by them may be urgently approved in the EU in late December, and the vaccine will be delivered to the EU before Christmas.

(Finish)